Quantcast

Latest Glycoproteins Stories

2014-06-30 23:08:23

New research study “Antibody Partnering Terms and Agreements” worked out by CurrentPartnering is now available at MarketPublishers.com. London, UK (PRWEB) June 30, 2014 What are the major big pharma companies involved in the antibody market space? What are the prevailing trends in antibody dealmaking in the overall biopharma industry since 2007? What does the company’s recent antibody dealmaking activity look like? What is actually granted by the antibody dealmaking agreement to a...

2014-06-27 23:09:30

Slide represents new diagnostic tool for detection of PEDV antibody. Pullman, WA (PRWEB) June 27, 2014 VMRD announced today the availability of a substrate slide that can be used for the detection of antibody to porcine epidemic diarrhea virus (PEDV). The slides are of twelve-well, Teflon-masked format with a substrate of fixed (killed), PEDV-infected Vero cells interspersed with non-infected Vero cells. “This substrate slide is the first quality-controlled FA diagnostic tool for...

2014-06-24 08:32:22

Interlaken Leadership Awards Program Supports Original Research in the Field of Neuroimmunology KING OF PRUSSIA, Pa., June 24, 2014 /PRNewswire/ -- CSL Behring announced today that Bart C. Jacobs, M.D., Ph.D., Erasmus University Medical Center, Rotterdam, Netherlands, is the recipient of the 2014 Interlaken Leadership Awards for original research in the field of neuroimmunology. Established in 2010, this annual global awards program provides monetary grants and/or product supply for...

2014-06-18 23:16:14

Bacterial recombinant protein expression is now available as a service at Maine Biotechnology Services. When MBS develops recombinant antigen for a hybridoma development, the end use application of the antibodies is considered during every phase of antigen production. Portland, Maine (PRWEB) June 18, 2014 Maine Biotechnology Services is announcing the addition of Bacterial Recombinant Protein Expression and Purification services to compliment our complete antibody service offering, adding...

2014-06-11 08:29:19

LA JOLLA, Calif. and SHANGHAI, June 11, 2014 /PRNewswire/ -- RuiYi, Inc., a global therapeutic innovation leader, announced today the close of a $4 million debt financing from Silicon Valley Bank to advance a pipeline of novel monoclonal antibodies (mAb) targeting G protein coupled receptors (GPCRs). RuiYi plans to file an IND and initiate clinical trials in multiple countries in 2015 for the company's lead asset, RYI-008, a novel anti-IL-6 mAb for rheumatoid arthritis and cancer....

2014-06-06 08:25:19

Premier US based supplier of HCG Injections and B12 Shots posts guest article that dives into some of the common questions and concerns about the use of human chorionic gonadotropin. HARTFORD, Conn., June 6, 2014 /PRNewswire-iReach/ -- US HCG Shots is not just a site that users can go to visit in order to find inexpensive vitamin injection blends, b12 and hcg. It is a site that provides numerous articles, often contributed by guest authors, that dive into different fitness programs or...

2014-06-04 08:29:36

MUMBAI and LA CHAUX-DE-FONDS, Switzerland, June 4, 2014 /PRNewswire/ -- - State-of-the-art Manufacturing Facility for Supply of Clinical Trial Material - With the Facility Glenmark has end-to-end Capabilities for the Development of Novel, State-of-the-art Monoclonal Antibodies Including Bi-specific Antibodies Glenmark Pharmaceuticals S.A (GPSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Limited, India (GPL), announced the opening of its new cGMP...

2014-05-28 08:31:16

MONROVIA, Calif., May 28, 2014 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today announced that the first subject has been dosed in a Phase 1a clinical trial of XmAb®7195. XmAb7195 is a monoclonal antibody engineered to suppress IgE via three distinct mechanisms of action as a potential treatment for asthma and...

2014-05-28 04:24:24

BREDA, The Netherlands, May 28, 2014 /PRNewswire/ -- arGEN-X, a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, announced today the initiation of a collaboration with Bayer Pharma AG (Bayer), leveraging arGEN-X's SIMPLE Antibody(TM) technology for the discovery and development of therapeutic antibodies. The collaboration centers on a novel approach to...

2014-05-27 23:11:01

Immunoglobulins or antibodies are proteins used by the immune system to neutralize pathogens including bacteria and viruses. The Life, Earth & Health Sciences Magazine EurekaMag.com has published 31,900 articles covering the interactions between a wide variety of immunoglobulins and pathogens particularly in humans. Mannheim, Germany (PRWEB) May 27, 2014 EurekaMag.com has published 31,900 articles on the importance of immunoglobulins for identifying and neutralizing pathogens such as...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related